Penobscot Investment Management Company Inc. Acquires New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Penobscot Investment Management Company Inc. acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,520 shares of the financial services provider’s stock, valued at approximately $206,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. International Assets Investment Management LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at $76,425,000. Itau Unibanco Holding S.A. purchased a new position in iShares Biotechnology ETF during the 3rd quarter valued at about $48,242,000. Miracle Mile Advisors LLC grew its holdings in iShares Biotechnology ETF by 0.4% during the 3rd quarter. Miracle Mile Advisors LLC now owns 325,333 shares of the financial services provider’s stock valued at $39,785,000 after buying an additional 1,399 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich increased its position in shares of iShares Biotechnology ETF by 3.7% during the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 293,097 shares of the financial services provider’s stock valued at $35,843,000 after buying an additional 10,542 shares during the period. Finally, Raymond James Financial Services Advisors Inc. lifted its holdings in shares of iShares Biotechnology ETF by 8.9% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock worth $20,879,000 after buying an additional 12,611 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $129.49 on Thursday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16. The company has a fifty day moving average price of $133.96 and a 200-day moving average price of $129.92.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.